- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05927792
Efficacy and Mechanism of Repetitive Transcranial Magnetic Stimulation in Children With Autism Spectrum Disorders
Efficacy and Mechanism of Repetitive Transcranial Magnetic Stimulation in Children With Autism Spectrum Disorders: a Multicenter, Randomized Controlled Trial
Study Overview
Status
Conditions
Detailed Description
This study is a prospective, multicenter, randomized, single-blind controlled trial. Shanghai Xinhua hospital, Qilu hospital and Zhengzhou Children's hospital expect to enroll a total of 200 children with autism spectrum disorders (ASD) to participate in this trial.
The children seen at Department of Developmental Behavioral Child Health, who meet the The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition(DSM-5) ASD diagnostic criteria and strict inclusion/exclusion criteria, can be enrolled for the intervention after informed consent.
At each study center, participants will be randomized into intervention group and sham group stratified by IQ level. The participants, their legal guardians, and the assessors were unaware of the grouping except for the intervention operator (single-blind).
During the trial, participants in intervention group will receive accelerated continuous theta-burst stimulation (a-cTBS) on the left primary motor cortex (M1) for 5 consecutive days. The sham group will be stimulated with a pseudo-stimulation coil, which emitted sounds with the same intensity, rhythm and vibratory sensation as the real stimulation, and the intervention target, duration and frequency are the same as the real intervention group.
All participants need to complete clinical assessments within 2 weeks before the cTBS intervention (pre-cTBS), repeated within 3 days after the completion of the cTBS course (post-cTBS) and 1 month following the last cTBS session (one month follow-up), respectively.
The investigators hope to further explore the effectiveness of accelerated continuous theta-burst stimulation (a-cTBS) over the left primary motor cortex (M1) to improve core symptoms in ASD children based on a previous open-label clinical trial and investigate the appropriate intervention model, effective adaptation population and underlying neurological mechanisms.
Study Type
Enrollment (Actual)
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Locations
-
-
Henan
-
Zhengzhou, Henan, China, 450000
- Henan Children's Hospital
-
-
Shandong
-
Qilu, Shandong, China, 250000
- Qilu Hospital of Shandong University
-
-
Shanghai Municipality
-
Shanghai, Shanghai Municipality, China, 200092
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Children aged 4-10 years old
- Meet the diagnostic criteria for ASD of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)
- ASD Diagnosis confirmed by the Autism Diagnostic Observation Schedule (ADOS) or Autism Diagnostic Interview, Revised (ADI-R)
- IQ of 50 or above
- Provide written informed consents
Exclusion Criteria:
- With metal implants in the body
- History of epilepsy or other neurological disease
- Require surgical treatment due to structural abnormalities indicated by brain MRI
- Diagnosed with genetic and chromosomal abnormalities
- With psychiatric/mental disorder (e.g., very early-onset schizophrenia) other than ASD
- Suffer from serious heart disease and/or severe hearing impairment
- Intracranial hypertension
- Participating in other clinical trials
- Participants who received other interventions within 4 weeks prior to enrollment.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention Group
participants in intervention group will receive accelerated continuous theta-burst stimulation (a-cTBS) on the left primary motor cortex (M1) for 5 consecutive days.
|
Participants in intervention group will receive cTBS over the left M1for 5 consecutive days.
The detailed parameters as follows: 80% of resting motor threshold (RMT), 60 cycles of 10 bursts of three pulses at 50 Hz were delivered in 2-second trains (5 Hz) with no intertrain interval (i.e.
triplet standard cTBS, 1800 pulses, 120s).
Stimulation sessions were delivered hourly, 10 sessions were applied per day (18,000 pulses/day).
|
|
Sham Comparator: Sham Group
The sham group will be stimulated with a pseudo-stimulation coil, which emitted sounds with the same intensity, rhythm and vibratory sensation as the real stimulation, and the intervention target, duration and frequency are the same as the real intervention group.
|
The sham group will be stimulated with a pseudo-stimulation coil, which emitted sounds with the same intensity, rhythm and vibratory sensation as the real stimulation, and the intervention target, duration and frequency are the same as the real intervention group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes of Social Responsiveness Scale, Second Edition (SRS-2) scores from pre-intervention to post-intervention
Time Frame: within 2 weeks before the intervention (pre-intervention), within 3 days after the completion of the intervention course (post-intervention)
|
SRS provides the multi-dimensional measure of social interaction allowing the rating of social impairment in ASD.
SRS generates a total score and five theoretical subscale scores (labeled social awareness, social cognition, social communication, social motivation, restricted interests and repetitive behavior), and higher scores are indicative of greater social impairment.
|
within 2 weeks before the intervention (pre-intervention), within 3 days after the completion of the intervention course (post-intervention)
|
|
Changes of Social Responsiveness Scale, Second Edition (SRS-2) scores from pre-intervention to 1 month follow-up
Time Frame: within 2 weeks before the intervention (pre-intervention), 1 month following the last intervention session (one month follow-up)
|
SRS provides the multi-dimensional measure of social interaction allowing the rating of social impairment in ASD.
SRS generates a total score and five theoretical subscale scores (labeled social awareness, social cognition, social communication, social motivation, restricted interests and repetitive behavior), and higher scores are indicative of greater social impairment.
|
within 2 weeks before the intervention (pre-intervention), 1 month following the last intervention session (one month follow-up)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Chinese Communicative Development Inventory (CCDI)
Time Frame: within 2 weeks before the intervention (pre-intervention), 1 month following the last intervention session (one month follow-up)
|
a parent questionnaire serves as a powerful tool to evaluate the early vocabulary development and language skills of older children with developmental disorders and the effectiveness of their interventions.
CCDI yields two subscale scores, including words produced score and sentence complexity score.Higher scores suggest better language level.
|
within 2 weeks before the intervention (pre-intervention), 1 month following the last intervention session (one month follow-up)
|
|
Language Comprehension Test
Time Frame: within 2 weeks before the intervention (pre-intervention), 1 month following the last intervention session (one month follow-up)
|
Peabody Picture Vocabulary Test (PPVT) is a standard assessment tool for measuring single-word comprehension, to objectively evaluate the language ability of the children involved in our study. Higher scores suggest better language level. Meanwhile, a sentence-picture matching test will be administered to test children's language comprehension abilities in the syntactic domain. |
within 2 weeks before the intervention (pre-intervention), 1 month following the last intervention session (one month follow-up)
|
|
Multilingual Assessment Instrument for Narratives (MAIN)
Time Frame: within 2 weeks before the intervention (pre-intervention), 1 month following the last intervention session (one month follow-up)
|
assess narrative comprehension and production skills of children who exhibited a certain level of expressive ability (at least can use flexible phrases).In this test, children tell or retell the stories and answer some questions, with assessors evaluating performance across four dimensions: story structure, structural complexity, internal state terms, and comprehension questions.
Higher scores suggest better language level.
|
within 2 weeks before the intervention (pre-intervention), 1 month following the last intervention session (one month follow-up)
|
|
Clinical Global Impression Scale (CGI)
Time Frame: within 3 days after the completion of the intervention course (post-intervention), 1 month following the last intervention session (one month follow-up)
|
we used CGI-I to rate how much the patient's illness has improved or worsened relative to a baseline measurement (a seven-point scale: 1 = "very much improved" to 7 = "very much worse")
|
within 3 days after the completion of the intervention course (post-intervention), 1 month following the last intervention session (one month follow-up)
|
|
Vineland Adaptive Behavior Scales, Third Edition (Vineland-3)
Time Frame: within 2 weeks before the intervention (pre-intervention), 1 month following the last intervention session (one month follow-up)
|
The Vineland Adaptive Behavior Scales were designed to address adaptive behavior, or the personal and social skills necessary for everyday independent living.
For individuals with ASDs, the Vineland can be used for tracking and reporting progress of intervention or treatment.
Domains of adaptive functioning assessed with the Vineland include: Communication, Daily Living Skills, Socialization, Motor Skills.
The higher scores suggest better adaptive level.
|
within 2 weeks before the intervention (pre-intervention), 1 month following the last intervention session (one month follow-up)
|
|
Electroencephalography (EEG)
Time Frame: within 2 weeks before the intervention (pre-intervention), within 2 days after the completion of the intervention course (post-intervention)
|
Electroencephalography (EEG): We plan to collect resting-state and task-related EEG data from children with ASD at baseline, after 5 days of intervention after intervention to evaluate changes in power spectrum and inter-trial phase coherence (ITPC) in the alpha and theta frequency bands at different time points.
The EEG data will be collected using a 128-channel EEG system with a sampling rate of 1000 Hz and a reference electrode at Cz (central zero).
Prior to data collection, we will ensure that the resistance of each channel is below 100 kΩ.
|
within 2 weeks before the intervention (pre-intervention), within 2 days after the completion of the intervention course (post-intervention)
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Fei Li, MD, PhD, Shanghai Jiaotong University School of Medicine Xinhua Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- XHEC-C-2023-043
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorder
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Istituto Clinico HumanitasRecruitingAutism | Autism Spectrum Disorder (ASD) | Autism DisorderItaly
-
The Children's Hospital of Zhejiang University...Not yet recruitingAutism | Autism Spectrum Disorder (ASD)China
-
Poznan University of Physical EducationCompletedAutism | Autism Spectrum Disorder (ASD)Poland
-
Adia Med of Winter Park LLCActive, not recruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Poznan University of Physical EducationNational Science Centre, PolandCompletedAutism Spectrum Disorder | ASD | Autism Spectrum Disorder High-Functioning | Autism SpectrumPoland
-
Blinklab LimitedRecruitingAutism Spectrum Disorder | Autism | Neurodevelopmental Conditions | Autism Spectrum Disorder (ASD)United States
-
Stanford UniversityJohn and Marcia Goldman FoundationNot yet recruitingAutism | Autism Spectrum Disorder (ASD)United States
-
National Cheng-Kung University HospitalCompletedAutism Spectrum Disorder (ASD) | Autism Spectrum Disorder High-FunctioningTaiwan
-
Healing Hope InternationalKurve Technology Inc.Enrolling by invitationNeurodevelopmental Disorders | Autism Spectrum Disorder | Autistic Disorder | Autism Spectrum Disorder (ASD) | Autistic Disorders Spectrum | Autism Spectrum Disorder High-Functioning | Autism Spectrum Disorder With Impaired Functional Language | Autistic Disorder of Childhood Onset With Full Syndrome and other conditionsUnited States
-
Stanford UniversityCalifornia Department of Developmental ServicesActive, not recruitingAutism Spectrum Disorder | Autistic Disorder | Autism | Autism Spectrum Disorders | Autistic Disorders Spectrum | Autistic Spectrum Disorder | Autistic Spectrum DisordersUnited States
Clinical Trials on repeated transcranial magnetic stimulation (continuous theta-burst stimulation)
-
University Hospital, LilleTerminatedStroke | Transcranial Magnetic Stimulation | Hemiparesis | Brain ConnectivityFrance
-
Michael J. Wesley, PhDRecruitingAlcohol Risk BehaviorsUnited States
-
Canadian Institutes of Health Research (CIHR)Completed
-
University of CalgaryActive, not recruiting
-
Mary Phillips, MD MD (Cantab)Milken InstituteCompletedBipolar DisorderUnited States
-
Mary Phillips, MD MD (Cantab)National Institute of Mental Health (NIMH)CompletedBipolar DisorderUnited States
-
Boston CollegeCompleted
-
University of BernTerminatedSchizo Affective Disorder | Schizophrenia; Psychosis | Schizophrenia and Related Disorders | Brief Psychotic DisorderSwitzerland
-
Dartmouth-Hitchcock Medical CenterNot yet recruitingObsessive-Compulsive Disorder (OCD)
-
University of ArizonaNational Institute on Aging (NIA)CompletedHealthy AgingUnited States